Hospitals buy, use and discard more than almost any other sector
Healthcare is one of the largest procurement and waste streams in the economy. A hospital buys everything from syringes and gowns to imaging machines and surgical robots, uses most of it once or for a fixed life, and then pays again to dispose of it. For years the model was simple: sterilise where regulation demanded it, landfill or incinerate the rest, and treat procurement as a cost-to-budget exercise. The Green Deal is changing that model from both ends.
The European Green Deal is not an environmental wish-list. It is a regulatory and investment programme that is rewriting product design, public purchasing, corporate reporting and waste rules. For healthcare providers, insurers, device manufacturers and investors, it means the linear buy-use-dispose model is becoming a source of compliance cost, supply risk and stranded asset risk. The question is no longer whether a hospital wants to be green. It is whether its procurement, balance sheet and supply chain are ready for a system where products must be designed to last, traced through a Digital Product Passport, bought against circular criteria, and reported under CSRD.
The supply chain
Healthcare value loop
Outer ring: the healthcare supply chain. Purple: virgin critical raw materials entering the system. Inner arcs: circular loops returning devices, equipment and materials upstream, coloured by value retained. Clay: downcycled material still in use. Red: value lost to single-use disposal, incineration and landfill.
R-ladder · value kept in the loop
- R0–R2Smarter use & design cuts virgin inflowRefuse, rethink, reduce
- R3–R7Extend lifespanReuse, repair, refurbish, repurpose
- R8RecycleMechanical & chemical recycling
- R9Recover energyEnergy recovery
Reserved channels · never used on the ladder
- virginVirgin inputVirgin rare earths, platinum, lithium and polymers
- cascadeCascadeDowncycled plastics and metals
- leakageLeakageLandfill, incineration & emissions
- chainThe chainPrimary value chain path
Value
Value sits in devices, equipment and contracted services at stages two to four.
Risk
Risk sits at the two ends. Concentrated critical-material supply at the front, and take-back, reprocessing and waste cost at the back.
Your role
Decision-maker
The Green Deal turns procurement into a balance-sheet and risk question.
Healthcare spending is being re-regulated around circular performance. The organisations that map ESPR, Digital Product Passport, CSRD and Green Public Procurement obligations early will have lower compliance cost, more resilient supply chains and a procurement advantage. The ones that wait will be buying data and redesigning products under deadline. This is a capital-allocation and risk-management question before it is a sustainability one.
Manager
This is where the policy becomes a specification.
Procurement owns the tender criteria that will select Green Deal-ready suppliers. Operations owns the reuse, reprocessing and waste streams that determine whether circular claims are real. Sustainability owns the CSRD/ESRS E5 data and the narrative. The internal conversation lands hardest when it shows up in a supplier scorecard or an asset-disposal decision, not in a report.
Employee
You see where single-use could become reusable.
You know which devices are discarded unused, where sterilisation could replace disposables, and where waste streams contain recoverable value. The most useful thing you can do is make those observations visible to the people who own procurement and budgets, because the Green Deal is about to turn them into cost lines and opportunities.
The trap is treating the Green Deal as a sustainability report
The common failure in healthcare is to fold the Green Deal into a corporate social responsibility or annual-sustainability-reporting exercise. Ecodesign, procurement criteria, Digital Product Passport data, CSRD reporting and critical-material risk are separate systems with separate owners, timelines and data needs. Buying a line of recycled-content products does not solve reprocessing infrastructure. Publishing a CSRD report does not reduce supply concentration. They connect, but they are not the same, and treating them as one is how a health system pays the compliance cost without capturing the circular value. So the first question, before the spending starts, is which pressure is actually binding. For a large hospital group, procurement criteria and CSRD reporting may lead. For a device manufacturer, ESPR and the Digital Product Passport are the urgent ones. For an investor, critical-material exposure and stranded-asset risk in the portfolio may matter most.
The pressure with a deadline: the Green Deal's product and reporting rules
The EU Green Deal has produced a stack of dated obligations that reach healthcare directly. The Ecodesign for Sustainable Products Regulation (ESPR), which entered into force on 28 July 2024, will set mandatory ecodesign requirements for product groups including textiles, furniture, mattresses, tyres, and eventually medical devices and equipment. The Digital Product Passport (DPP), required under ESPR, will force manufacturers to share standardised data on durability, repairability, recycled content, hazardous substances and end-of-life handling. The Corporate Sustainability Reporting Directive (CSRD) and the ESRS E5 resource-use and circular-economy standard require in-scope companies to report circular metrics from 2024 onwards, with phased rollout through 2028. The Packaging and Packaging Waste Regulation (PPWR), provisionally agreed in 2024, sets reuse and recycling targets for 2030, 2035 and 2040. Together they mean that by the early 2030s a hospital's suppliers will have to prove circular performance, and hospitals themselves will have to report on resource use.
- ESPR entered into force 28 Jul 2024
- Digital Product Passport required for regulated product groups
- CSRD / ESRS E5 reporting phased 2024–2028
- PPWR targets for 2030, 2035 and 2040
- Green Public Procurement criteria being updated across Member States
For a hospital, insurer or device maker this is not a distant policy discussion. It is a procurement-specification, data-system and reporting question with a deadline. The organisations that map these obligations early will have cleaner supply chains and lower compliance cost. The ones that wait will pay a premium for data they do not have and products that may not qualify.
The pressure without a fixed date: single-use dependency and critical material concentration
Healthcare has become reliant on single-use devices and disposable consumables. The logic was infection control, convenience and predictable unit cost. The structural problem is that this model concentrates supply risk, locks in waste cost and embeds critical raw materials — rare earths in MRI machines, platinum in diagnostic equipment, lithium in mobile devices and batteries — that are sourced from a small number of countries. When a supply shock hits, the hospital cannot simply reuse or repair its way out because the infrastructure and the procurement contracts are built around disposability.
The Green Deal pushes in, but the system cannot absorb it
Healthcare's circular pressures are arriving faster than the operating model can adapt.
Pressures arriving
Design rules
ESPR and the DPP will require products to be traceable, repairable and recyclable by design.
Procurement criteria
Green Public Procurement will reward circular products and penalise linear ones in tender scoring.
Reporting exposure
CSRD/ESRS E5 forces disclosure of resource use, circular inputs and waste generation.
Material risk
Critical raw material concentration creates supply shocks and price volatility for devices.
What the system would need to absorb them
Reuse infrastructure
Sterilisation, remanufacturing and take-back capacity that meets clinical and regulatory standards.
Data integration
Digital Product Passport data flowing into procurement, asset management and reporting systems.
Contract redesign
Procurement that pays for performance and outcome, not just unit volume.
The gap becomes a cost or an advantage
Organisations that build circular readiness into procurement and asset management turn the same rules into a competitive advantage. Those that treat them as a compliance add-on absorb cost without capturing value.
The structural opportunity is to redesign the procurement and use model before the rules force it. Reprocessing, remanufacturing, reusable systems and critical-material recovery are not fringe sustainability ideas; they are the business model that aligns with where the Green Deal is heading.
How the Green Deal lands in different markets
Geography is the heading. The circularity figure beneath is an economy-wide indicator, not a healthcare-specific recycling rate.
European Union
12.2% circular material use, Eurostat 2024
The EU is the regulatory front line. ESPR, the Digital Product Passport, CSRD/ESRS E5, the Packaging and Packaging Waste Regulation and updated Green Public Procurement criteria form a coherent push to make circularity the default.
- ESPR entered into force 28 July 2024; first working plan covers 2025–2030
- Digital Product Passport will be mandatory for regulated product groups, starting with textiles and batteries
- CSRD reporting phased in from 2024; ESRS E5 covers resource use and circular economy
- PPWR sets reuse and recycling targets for 2030, 2035 and 2040
- Green Public Procurement can shift roughly €2 trillion of public spending annually
International
6.9% global circularity, Circularity Gap Report 2026
Outside the EU the picture is fragmented. The United States has a mature FDA-regulated device reprocessing sector, while many markets still treat single-use as the only safe model.
- US FDA has regulated third-party reprocessing of single-use devices since 2000
- Some Asian manufacturing hubs dominate production of disposable medical supplies
- Global healthcare systems are only beginning to incorporate circular criteria into procurement
- The EU rules create a de facto benchmark for multinationals selling into Europe
Netherlands
32.7% circular material use, Eurostat 2024
The Netherlands has the EU's highest circular material use rate and is applying it to healthcare through national procurement and circular care initiatives.
- Dutch healthcare procurement is coordinated at national level through platforms such as Zorginkoop
- Circular procurement pilots are running in hospitals and care institutions
- The Netherlands is a major distribution hub for medical devices into Europe
- Strong sterilisation and reprocessing infrastructure supports a shift to reusable systems
Ireland
2.0% circular material use, Eurostat 2024
Ireland has one of the EU's lowest circular material use rates, but it is a major manufacturing base for medical devices and pharmaceuticals and has a large public health purchaser in the HSE.
- Ireland is one of the world's largest exporters of medical devices and pharmaceuticals
- The Health Service Executive (HSE) is one of the largest public procurers in the country
- Medical device manufacturing gives Ireland direct exposure to ESPR and Digital Product Passport rules
- Low domestic circular material use rate signals room for improvement in procurement and recovery infrastructure
Where does this leave you?
Five statements about Green Deal readiness in healthcare. Count the ones you can honestly answer yes to. Fewer yeses means an earlier starting point, not a failing grade.
- 1. We know which products and suppliers in our portfolio fall under ESPR, Digital Product Passport or PPWR requirements.
- 2. We have circular criteria — reuse, repairability, recycled content, take-back — embedded in our procurement process.
- 3. We can identify our major healthcare waste streams and any recovery or reprocessing opportunities within them.
- 4. We have assessed our exposure to critical raw materials in devices, equipment and batteries.
- 5. We have a plan to meet CSRD/ESRS E5 reporting on resource use and circular economy metrics.
Answer all five statements to see your readout.
Where to start
If: A hospital or care provider · Then: Start with procurement criteria and CSRD/ESRS E5 data. These are the levers you control directly.
If: A medical device or equipment manufacturer · Then: ESPR and Digital Product Passport readiness is your first question. Design for circularity before the rules force redesign.
If: An investor or insurer · Then: Map critical-material exposure and stranded-asset risk in the portfolio. The Green Deal re-prices linear business models.
If: A procurement platform or group purchasing organisation · Then: Build circular scoring and total-cost-of-ownership into tenders. That is where the market power sits.
Circular levers
Reprocessing and remanufacturing of medical devices
Regulated reprocessing of single-use devices, and remanufacturing of higher-value equipment, cuts waste and supply exposure while preserving clinical performance. It turns the device from a consumable into a recoverable asset.
Green Public Procurement and circular criteria
Embedding circular specifications, total-cost-of-ownership scoring and reuse targets into tenders redirects purchasing power toward products that are designed for the Green Deal rather than caught out by it.
Digital Product Passport integration
Using DPP data in procurement and asset management gives visibility into material content, repair options and end-of-life routes before a product is bought.
Design for circularity in devices and equipment
Working with suppliers to design out waste, reduce hazardous substances, standardise components and enable repair and upgrade extends asset life and protects against obsolescence.
Critical material recovery from healthcare waste
Recovering rare earths, precious metals and other critical inputs from end-of-life devices, batteries and diagnostic equipment turns a waste cost into a supply hedge.
Reusable systems and sterilisation infrastructure
Shifting from disposable to reusable instruments, textiles and packaging where clinically viable reduces the volume and cost of waste while lowering exposure to single-use supply shocks.
The same Green Deal rules that raise compliance cost also reward the organisations that redesign around reuse, recovery and transparency. The lever is not compliance alone; it is building the operating model that makes compliance profitable.